Birdwatch Archive - Rating Details

Birdwatch Note Rating

2023-08-25 22:07:58 UTC - SOMEWHAT_HELPFUL

Rated by Participant: 645FBCA3262AAC2ED92E7433511DCA0CD8173EDD264E3910E4B92003AA71E520
Participant Details

Original Note:

EBC-46 has shown efficacy to reduce cancer in animal studies only. Clinical trials have since commenced for skin, head and neck, and soft tissue cancers in humans. In 2020 the FDA approved an EBC-46–based medication Stelfonta, to treat mast cell cancer in dogs. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/

All Note Details

Original Tweet

All Information

noteId - 1695190002055970932
participantId -
raterParticipantId - 645FBCA3262AAC2ED92E7433511DCA0CD8173EDD264E3910E4B92003AA71E520
createdAtMillis - 1693001278046
version - 2
agree - 0
disagree - 0
helpful - 0
notHelpful - 0
helpfulnessLevel - SOMEWHAT_HELPFUL
helpfulOther - 0
helpfulInformative - 0
helpfulClear - 1
helpfulEmpathetic - 0
helpfulGoodSources - 1
helpfulUniqueContext - 0
helpfulAddressesClaim - 0
helpfulImportantContext - 0
helpfulUnbiasedLanguage - 1
notHelpfulOther - 1
notHelpfulIncorrect - 0
notHelpfulSourcesMissingOrUnreliable - 0
notHelpfulOpinionSpeculationOrBias - 0
notHelpfulMissingKeyPoints - 1
notHelpfulOutdated - 0
notHelpfulHardToUnderstand - 0
notHelpfulArgumentativeOrBiased - 0
notHelpfulOffTopic - 0
notHelpfulSpamHarassmentOrAbuse - 0
notHelpfulIrrelevantSources - 0
notHelpfulOpinionSpeculation - 0
notHelpfulNoteNotNeeded - 0
ratingsId - 1695190002055970932645FBCA3262AAC2ED92E7433511DCA0CD8173EDD264E3910E4B92003AA71E520